Viewing nowCombinationBalsafos Tablet 5/160 mg (Amlodipine Besylate, Valsartan)
Valsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.

MFDS item code 201308468 · Approved 2013.07.30 · Insurance code 644913600
Improvement in blood pressure control for essential hypertension
For patients with essential hypertension, blood pressure may not be sufficiently controlled with either amlodipine or valsartan alone. In such cases, using both medications together may lower blood pressure more effectively. Amlodipine dilates blood vessels to reduce blood pressure, while valsartan helps control blood pressure by inhibiting blood vessel constriction. The combination therapy of these two medications is effective in improving blood pressure control and reducing the risk of cardiovascular diseases. Therefore, the combined treatment of amlodipine and valsartan is used for the appropriate management of essential hypertension.
The recommended dose of Balsafos tablets is 1 tablet once daily, taken with water regardless of meals. It is recommended to take it at the same time every day (e.g., in the morning) if possible.
The safety and efficacy of this medication has not been established in pediatric patients under 18 years of age, and therefore its use is not recommended.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Do not take this medication if you are allergic to any of its active ingredients or similar medications, if you are pregnant or breastfeeding, or if you have severe kidney or liver diseases, or a history of specific heart diseases or angioedema. Patients with low sodium or fluid levels may experience hypotension; therefore, it is essential to manage such conditions before taking this medication and to monitor blood pressure and condition carefully during treatment. This medication can increase blood potassium levels, so if taken with potassium supplements or potassium-sparing diuretics, potassium levels should be checked frequently. Patients with renal impairment or kidney transplant recipients should use caution as this medication may affect renal function. If symptoms of angioedema occur, discontinue use immediately and do not resume. Patients with heart failure or post-myocardial infarction should carefully monitor renal function and blood pressure while on this medication, and patients with acute myocardial infarction should also be cautious. Dose adjustments may be necessary for individuals with impaired liver function, and this medication should not be used in severe liver disease cases. Dizziness or fatigue may occur during treatment, so caution is advised when driving or operating machinery. When combining this medication with other antihypertensive medications or specific drugs, interactions may occur; therefore, consultation with a doctor or pharmacist is necessary, especially for frequent checks of potassium levels, renal function, and blood pressure. This medication is not recommended for children under 18 years of age. Overdose may lead to severe hypotension or cardiac issues, so care should be taken to not exceed the prescribed dosage. If pregnant or planning to become pregnant, consultation with a doctor is essential before taking this medicine, and breastfeeding women should also avoid this treatment.
Hives, severe swelling (edema), angioedema, vasculitis, impaired liver function (hepatitis, jaundice), Stevens-Johnson syndrome, toxic epidermal necrolysis, severe allergic reactions, confusion, seizures, visual disturbances, paralysis, severe neurological symptoms, severe edema or urination issues, worsening heart failure, pulmonary edema, acute renal failure, myocardial infarction, severe hypotension, syncope, elevated serum potassium, renal failure, and kidney damage.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. Additionally, avoid storing it in excessively hot or cold places; storing it at room temperature between 1 degree and 30 degrees Celsius is safe.
Dark yellow oblong film-coated tablet
28 tablets (14 tablets/PTP packaging × 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.